{
  "trial_id": "NCT02298803",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, duration of type 2 diabetes, history of symptomatic or documented hypoglycaemia, current anti-diabetic medications, baseline blood glucose levels, baseline QT interval, presence of any cardiovascular conditions, family history of Long QT syndrome, baseline HbA1c levels, body mass index (BMI), blood pressure, lipid profile.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Diabetes duration",
          "duration of type 2 diabetes"
        ],
        [
          "HbA1c",
          "baseline HbA1c levels"
        ],
        [
          "Body Mass Index",
          "body mass index (BMI)"
        ],
        [
          "Systolic Blood Pressure",
          "blood pressure"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment",
        "Ethnicity: Caucasian",
        "Non-Caucasian",
        "Diabetes Treatment: Mono or dual therapy",
        "Triple or quadruple therapy",
        "Waist circumference",
        "Smoking Status: Current",
        "Former",
        "Lifelong non-smoker",
        "Alcohol consumption status: Consumer",
        "Abstainer",
        "Microvascular Complication Status: Present",
        "Absent"
      ],
      "remaining_candidate_features": [
        "history of symptomatic or documented hypoglycaemia",
        "current anti-diabetic medications",
        "baseline blood glucose levels",
        "baseline QT interval",
        "presence of any cardiovascular conditions",
        "family history of Long QT syndrome",
        "lipid profile."
      ]
    },
    "processed-gen-response": "Age, gender, duration of type 2 diabetes, history of symptomatic or documented hypoglycaemia, current anti-diabetic medications, baseline blood glucose levels, baseline QT interval, presence of any cardiovascular conditions, family history of Long QT syndrome, baseline HbA1c levels, body mass index (BMI), blood pressure, lipid profile."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Duration of Diabetes, History of Hypoglycemia, Current Sulfonylurea Use, Baseline Blood Glucose Levels, Baseline QT Interval, Concomitant Anti-diabetic Medications,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Diabetes duration",
          "Duration of Diabetes"
        ],
        [
          "Diabetes Treatment: Mono or dual therapy",
          "Current Sulfonylurea Use"
        ],
        [
          "Diabetes Treatment: Mono or dual therapy",
          "Concomitant Anti-diabetic Medications"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity: Caucasian",
        "Non-Caucasian",
        "Triple or quadruple therapy",
        "HbA1c",
        "Body Mass Index",
        "Waist circumference",
        "Systolic Blood Pressure",
        "Smoking Status: Current",
        "Former",
        "Lifelong non-smoker",
        "Alcohol consumption status: Consumer",
        "Abstainer",
        "Microvascular Complication Status: Present",
        "Absent"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "History of Hypoglycemia",
        "Baseline Blood Glucose Levels",
        "Baseline QT Interval"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Duration of Diabetes, History of Hypoglycemia, Current Sulfonylurea Use, Baseline Blood Glucose Levels, Baseline QT Interval, Concomitant Anti-diabetic Medications"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Diabetes Duration, Sulfonylurea Treatment Duration, HbA1c, BMI, Blood Pressure, Lipid Profile, History of Hypoglycaemia, History of Cardiovascular Disease.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Diabetes duration",
          "Diabetes Duration"
        ],
        [
          "HbA1c",
          "HbA1c"
        ],
        [
          "Body Mass Index",
          "BMI"
        ]
      ],
      "remaining_reference_features": [
        "Region of Enrollment",
        "Ethnicity: Caucasian",
        "Non-Caucasian",
        "Diabetes Treatment: Mono or dual therapy",
        "Triple or quadruple therapy",
        "Waist circumference",
        "Systolic Blood Pressure",
        "Smoking Status: Current",
        "Former",
        "Lifelong non-smoker",
        "Alcohol consumption status: Consumer",
        "Abstainer",
        "Microvascular Complication Status: Present",
        "Absent"
      ],
      "remaining_candidate_features": [
        "Sulfonylurea Treatment Duration",
        "Blood Pressure",
        "Lipid Profile",
        "History of Hypoglycaemia",
        "History of Cardiovascular Disease."
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Diabetes Duration, Sulfonylurea Treatment Duration, HbA1c, BMI, Blood Pressure, Lipid Profile, History of Hypoglycaemia, History of Cardiovascular Disease."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, body mass index (BMI), duration of diabetes, type of sulfonylurea treatment, history of cardiovascular disease, presence of microvascular complications, HbA1c, fasting glucose, lipid profile, blood pressure, heart rate, presence of autonomic neuropathy.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Body Mass Index",
          "body mass index (BMI)"
        ],
        [
          "Diabetes duration",
          "duration of diabetes"
        ],
        [
          "Diabetes Treatment: Mono or dual therapy",
          "type of sulfonylurea treatment"
        ],
        [
          "HbA1c",
          "HbA1c"
        ],
        [
          "Microvascular Complication Status: Present",
          "presence of microvascular complications"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment",
        "Ethnicity: Caucasian",
        "Non-Caucasian",
        "Triple or quadruple therapy",
        "Waist circumference",
        "Systolic Blood Pressure",
        "Smoking Status: Current",
        "Former",
        "Lifelong non-smoker",
        "Alcohol consumption status: Consumer",
        "Abstainer",
        "Microvascular Complication Status: Absent"
      ],
      "remaining_candidate_features": [
        "history of cardiovascular disease",
        "fasting glucose",
        "lipid profile",
        "blood pressure",
        "heart rate",
        "presence of autonomic neuropathy"
      ]
    },
    "processed-gen-response": "Age, sex, body mass index (BMI), duration of diabetes, type of sulfonylurea treatment, history of cardiovascular disease, presence of microvascular complications, HbA1c, fasting glucose, lipid profile, blood pressure, heart rate, presence of autonomic neuropathy."
  }
}